DrugJul 29, 2026
Rohto Cooling Eye Drops ALL-IN-ONE recall — FDA D-0715-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
Latest records
Latest recalls — page 9
The newest recall records with useful source details are listed here.
DrugJul 29, 2026
Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10) recall — FDA D-0735-2026
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12…
Class IIIFDA: OngoingAscend Laboratories, LLC
DrugJul 29, 2026
Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle recall — FDA D-0732-2026
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be…
Class IFDA: OngoingJB Chemicals and Pharmaceuticals Ltd
DrugJul 29, 2026
CYPROHEPTADINE HYDROCHLORIDE Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL recall — FDA D-0724-2026
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Class IIFDA: OngoingRising Pharma Holding, Inc.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) unit dose blisters recall — FDA D-0708-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL recall — FDA D-0725-2026
Presence of Particulate Matter: Hair was found in product
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Xylocaine recall — FDA D-0729-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Rohto Cooling Eye Drops Optic Glow recall — FDA D-0718-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters recall — FDA D-0707-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle recall — FDA D-0712-2026
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Class IIFDA: OngoingAscend Laboratories, LLC
DrugJul 29, 2026
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use recall — FDA D-0713-2026
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Class IIIFDA: OngoingAsclemed USA Inc.
DrugJul 29, 2026
Rohto Cooling Eye Drops Max Strength recall — FDA D-0717-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL recall — FDA D-0726-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10) recall — FDA D-0736-2026
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12…
Class IIIFDA: OngoingAscend Laboratories, LLC
DrugJul 29, 2026
Rohto Cooling Eye Drops Dry Aid recall — FDA D-0720-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Xylocaine recall — FDA D-0728-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Rohto Cooling Eye Drops Digi Eye recall — FDA D-0719-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose recall — FDA D-0710-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Naropin recall — FDA D-0727-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose recall — FDA D-0711-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Rohto Cooling Eye Drops Cool Relief recall — FDA D-0722-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters recall — FDA D-0709-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Rohto Cooling Eye Drops Max Strength recall — FDA D-0716-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
FoodJul 29, 2026
GELLERT GLOBAL GROUP Fusia, Asian Inspirations, Kimchi & Tofu Kimbap, 8.1 OZ recall — FDA H-1186-2026
Undeclared Allergen (Fish)
Class IFDA: OngoingGELLERT GLOBAL GROUP
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026144 records · 4 categoriesJuly 2026363 records · 4 categoriesJune 2026368 records · 4 categoriesMay 2026327 records · 4 categoriesApril 2026405 records · 4 categoriesMarch 2026170 records · 3 categoriesFebruary 2026120 records · 4 categoriesJanuary 202661 records · 3 categoriesDecember 202599 records · 3 categoriesNovember 202596 records · 3 categoriesOctober 2025133 records · 3 categoriesSeptember 2025115 records · 3 categories